Difference between revisions of "He JT, et al. Mol. Cell. Proteom. (2012) cited as Ref 679 in DOI: 10.1038/s41392-020-0110-5 (Q9942)"
Jump to navigation
Jump to search
(Created a new Item: #quickstatements; #temporary_batch_1589975872009) |
(Created claim: Page(s) (P105): M111.010744-, #quickstatements; #temporary_batch_1590074839150) |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / First Author string | |||||||||||||||
| + | He JT | ||||||||||||||
| Property / First Author string: He JT / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / DOI Identifier | |||||||||||||||
| + | |||||||||||||||
| Property / DOI Identifier: 10.1074/mcp.M111.010744 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2012
| ||||||||||||||
| Property / Publication Date: 2012 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Published In Name String | |||||||||||||||
| + | Mol. Cell. Proteom. | ||||||||||||||
| Property / Published In Name String: Mol. Cell. Proteom. / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Volume | |||||||||||||||
| + | 11 | ||||||||||||||
| Property / Volume: 11 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / title | |||||||||||||||
| + | CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays (English) | ||||||||||||||
| Property / title: CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays (English) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Page(s) | |||||||||||||||
| + | M111.010744- | ||||||||||||||
| Property / Page(s): M111.010744- / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| links / sliswiki / name | links / sliswiki / name | ||||||||||||||
| + | |||||||||||||||
Latest revision as of 15:49, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
He JT, et al. Mol. Cell. Proteom. (2012) cited as Ref 679 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
He JT
0 references
2012
0 references
Mol. Cell. Proteom.
0 references
11
0 references
CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays (English)
0 references
M111.010744-
0 references
